Cantitate/Preț
Produs

Biosimilar Drug Product Development: Drugs and the Pharmaceutical Sciences

Editat de Laszlo Endrenyi, Dr. Paul Declerck, Shein-Chung Chow
en Limba Engleză Paperback – 30 iun 2020
When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Citește tot Restrânge

Din seria Drugs and the Pharmaceutical Sciences

Preț: 43620 lei

Preț vechi: 58655 lei
-26%

Puncte Express: 654

Preț estimativ în valută:
7725 9022$ 6711£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367552497
ISBN-10: 0367552493
Pagini: 496
Ilustrații: 90
Dimensiuni: 156 x 234 x 27 mm
Greutate: 0.92 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences


Public țintă

Academic and Professional Practice & Development

Cuprins

Analytical characterization. Immunogenicity. Animal studies. Clinical development. Manufacturing, process control. Extrapolation of indications. Interchangeability, substitution. Pharmacovigilance. Statistical issues. Regulatory issues.

Descriere

When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.